Faeth Therapeutics appoints two senior VPs
Biotech firm Faeth Therapeutics adds two senior executives to its leadership team amid expansion.
Faeth Therapeutics Inc. announced the appointment of two senior vice presidents to its executive team, according to a company filing.
The appointments reflect the biotechnology company’s ongoing growth and strategic expansion in its pipeline development. The newly named senior VPs will oversee key operational areas, though specific titles and responsibilities were not disclosed in the filing.
Faeth Therapeutics, which focuses on oncology and precision medicine, has not provided further details on the appointees or their prior roles. The company’s leadership additions follow recent corporate milestones as it advances its clinical programs.
The biotech firm remains privately held and did not disclose financial terms or additional context regarding the appointments.
Helena covers corporate news for listed and private companies across Europe, from strategy shifts to leadership changes, with an eye for what a story signals about the broader market.
More from Helena Vásquez →